Fund Holdings — GILEAD SCIENCES, INC.

Total Portfolio Value:
$1.79B
Total Bought:
$75.30M
Total Sold:
$5.07M
Net Transaction:
+$70.23M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Lakefront Biotherapeutics NVADR(LKFT)16,707,47716,707,4770$467.64M$578.75M32.31%+$111.10M
Arcellx Inc
COMMON STOCK
6,720,8036,720,8030$442.56M$551.78M30.80%+$109.21M
Arcus Biosciences, Inc.(RCUS)31,424,76031,424,7600$255.80M$427.38M23.86%+$171.58M
Assembly Biosciences Inc2,209,4714,505,391+2,295,920$40.04M$115.34M6.44%+$75.30M
Merus N V452,527452,5270$23.80M$42.61M2.38%+$18.80M
Tango Therapeutics, Inc.(TNGX)4,854,4434,854,4430$24.85M$40.78M2.28%+$15.92M
Kyverna Therapeutics, Inc.(KYTX)4,126,1194,126,1190$12.67M$24.76M1.38%+$12.09M
Xilio Therapeutics, Inc.(XLO)9,105,4519,105,4510$6.19M$7.67M0.43%+$1.48M
Cypherpunk Technologies Inc.(CYPH)5,319,1485,319,1480$1.58M$2.41M0.13%+$835.6K
Allogene Therapeutics Inc1,156,6890-1,156,689$1.31M$0—-$1.31M
Kalaris Therapeutics, Inc.(KLRS)317,7890-317,789$848.5K$0—-$848.5K
Hookipa Pharma Inc1,875,9450-1,875,945$2.35M$0—-$2.35M
Barinthus Biotherapeutics PlADS99,4780-99,478$92.5K$0—-$92.5K
Ikena Oncology Inc348,5340-348,534$467.1K$0—-$467.1K
Page 1 of 1
GILEAD SCIENCES, INC. — 13F Holdings — Q3 2025 | TickerTrail